Back to top

Image: Bigstock

Altria Stock Rises 34.2% Year to Date: Is There More Upside Ahead?

Read MoreHide Full Article

Key Takeaways

  • Altria's shares have climbed 34.2% year to date, outperforming the tobacco industry and broader market.
  • MO's Q3 adjusted EPS rose 4.8%, while on! shipment volumes grew 13.3%, supporting its smoke-free strategy.
  • MO raised its 2026 EPS outlook to $5.66-$5.74, though declining cigarette volumes and rising costs pose risks.

Altria Group, Inc.’s (MO - Free Report) shares have gained 34.2% so far this year, driven by strong pricing power, steady earnings growth, rising demand for its on! nicotine pouches and solid shareholder returns. The company's upbeat earnings outlook has further supported investor confidence.

MO stock has outperformed the Tobacco industry’s 21.3% growth, the Consumer Staples sector’s 16.5% gain and the S&P 500’s 7.2% rise. Among its peers, Philip Morris International (PM - Free Report) and British American Tobacco (BTI - Free Report) have gained 21.2% and 4.5%, respectively, while Turning Point Brands (TPB - Free Report) has plunged 54.3% over the same period.

MO Stock YTD Performance

Zacks Investment Research
Image Source: Zacks Investment Research

Technical indicators highlight Altria’s strength, with the stock last trading at $77.46, above its 50-day and 200-day moving averages of $72.49 and $68.34, respectively, signaling solid upward momentum. This technical setup points to positive sentiment surrounding the stock.

MO Stock Trades Above 50-Day & 200-Day Moving Averages

Zacks Investment Research
Image Source: Zacks Investment Research

Altria’s strong stock performance and positive technical indicators reflect investor confidence. However, assessing its long-term upside requires a closer look at the company’s underlying fundamentals, including its pricing power, earnings resilience and strategic growth initiatives.

Altria’s Winning Strategies

Altria continues to demonstrate earnings resilience through disciplined pricing and strong operational execution. In the third quarter of 2026, adjusted EPS increased 4.8% year over year to $1.52, while nine-month adjusted EPS rose 5.1% to $4.33. Smokeable products remained a key earnings driver, with adjusted operating companies income (“OCI”) growing 3.9% and adjusted OCI margins reaching 64.5%. This profitability strength reinforces Altria’s ability to navigate volume pressures and sustain earnings growth.

Altria is accelerating its smoke-free strategy through product innovation and broader distribution of on! PLUS. In the third quarter, on! shipment volumes grew 13.3% to 47.8 million cans, while on! retail share of the oral tobacco category edged up to 8.3%. The nationwide rollout of 12-milligram on! PLUS and new Blueberry Mint and Mango Pineapple flavors should strengthen consumer appeal, supporting long-term growth in the expanding nicotine-pouch category.

Altria’s data-driven portfolio strategy continues to strengthen its competitive position across cigarette price segments. In the third quarter of 2026, Marlboro’s share of the premium segment increased 0.3 percentage points year over year to 60%, supported by the introduction of Cowboy Cut. The offering targets price-sensitive premium smokers, helping Altria retain customers within the Marlboro franchise. This strategic approach reinforces brand loyalty and supports long-term profitability amid evolving consumer preferences and economic pressures.

Altria’s strong cash generation supports shareholder returns while providing flexibility for strategic investments. In the first nine months of 2026, the company returned more than $6 billion through dividends and share repurchases. Its board also increased the quarterly dividend 4.7% to $1.11 per share and expanded the buyback authorization by $1 billion. In the third-quarter earnings results, Altria raised its 2026 adjusted EPS guidance to $5.66-$5.74 from $5.61-$5.72, implying year-over-year growth of 4.5-6%.

How Are Estimates Stacking Up for MO?

Reflecting the positive sentiment around Altria, the Zacks Consensus Estimate for earnings per share has seen upward revisions. Over the past 30 days, earnings per share estimates for 2026 and 2027 have increased 3 cents and 4 cents to $5.70 and $5.89, respectively. Based on the revised estimates, MO is expected to deliver earnings growth of 5.2% in 2026 and 3.3% in 2027.

Zacks Investment Research
Image Source: Zacks Investment Research

Taking a Look at Altria Stock’s Valuation

The stock’s forward 12-month price-to-earnings (P/E) ratio stands at 13.21. This is below the industry’s average of 16.36, the sector’s 18.43 and the S&P 500’s 18.29. When measured against leading competitors, Philip Morris and Turning Point Brands trade at higher multiples of 21.74x and 20.54x, respectively, while British American Tobacco trades at a lower multiple of 11.54x.

MO P/E Ratio (Forward 12 Months)

Zacks Investment Research
Image Source: Zacks Investment Research

What Could Weigh on MO’s Growth?

Altria continues to face pressure from declining cigarette volumes and shifting consumer preferences. In the third quarter of 2026, domestic cigarette shipment volume declined 2.9% year over year, while inventory-adjusted volume fell an estimated 4%. Although higher pricing supported profitability, increased promotional investments, rising manufacturing costs and a greater mix of discount shipments remained headwinds. These pressures could limit revenue growth and challenge margin sustainability.

Altria’s oral tobacco business continues to face profitability challenges despite growth in nicotine pouches. In the third quarter, segment net revenues declined 0.1% year over year, while adjusted OCI fell 3.7% to $443 million. Shipment volumes decreased 4.3%, as growth in on! was more than offset by declining moist smokeless tobacco volumes. Continued promotional investments and higher operating costs could further weigh on profitability as Altria expands its smoke-free portfolio.

MO’s Investment Analysis

Altria’s strong year-to-date stock performance reflects the pricing power, earnings resilience and progress in expanding its smoke-free portfolio. Continued innovation in on! PLUS, strong cash generation and shareholder-friendly initiatives support its long-term prospects. Although declining cigarette volumes, rising costs and pressure on oral tobacco profitability remain concerns, the company’s upbeat earnings outlook and attractive valuation provide reasons for optimism. With a Zacks Rank #2 (Buy), MO remains an appealing choice for investors seeking steady earnings growth, attractive dividends and long-term value.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Published in